ATELVIA vs IBANDRONATE SODIUM

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Possible drug interaction. ATELVIA and IBANDRONATE SODIUM are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	ATELVIA	IBANDRONATE SODIUM
Rating	New	New
Pharmacy pays	~$73.02 /30	$2.81 /mL
Type	RX	RX
Active ingredient	RISEDRONATE SODIUM	IBANDRONATE SODIUM
Manufacturer	Apil	Sun Pharm
Dosage forms	Tablet, delayed release	Injectable, Solution, Tablet
Drug class	Bisphosphonate	Bisphosphonate
Boxed warning	None	None
Half-life	about 561 hours — roughly 23 days	—
Treats	Extramammary Paget Disease, Postmenopausal Osteoporosis	Postmenopausal Osteoporosis

atelvia ibandronate sodium

Rating

New

Pharmacy pays

~$73.02 /30

$2.81 /mL

Type

Active ingredient

RISEDRONATE SODIUM

IBANDRONATE SODIUM

Manufacturer

Apil

Sun Pharm

Dosage forms

Tablet, delayed release

Injectable, Solution, Tablet

Drug class

Bisphosphonate

Boxed warning

None

Half-life

about 561 hours — roughly 23 days

—

Treats

Extramammary Paget Disease, Postmenopausal Osteoporosis

Postmenopausal Osteoporosis

Frequently asked questions

What is the difference between Atelvia and Ibandronate Sodium?

Atelvia contains Risedronate Sodium, while Ibandronate Sodium contains Ibandronate Sodium — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.